Moreover, targeting kinase-mediated podosome formation, an inherent pathogenic LF property as shown here, as well as structural (TKS5 and its protein-protein interactions) or effector (MMP 2/9/14) podosome components, are very promising therapeutic targets in pulmonary fibrosis. This evidence concerns the gene SH3PXD2A and pulmonary fibrosis.